74% of SynBioBeta attendees are decision-makers. 38% are C-suite and Founders. Three days, one room, the highest concentration of bio + AI + capital leaders anywhere.

Your Booth. Their Budget.
SynBioBeta isn't a general industry conference. It's where the people making funding decisions, partnership deals, and technology bets come to find what's next. Here's who you'll be in front of.
More Than a Logo on a Lanyard
Sponsorship at SynBioBeta puts you where the conversations happen — on stage, in meeting rooms, at lunch tables, and on every attendee's badge. Here's how.
Why People Keep Coming Back

Zack Abbott
Founder & CEO


Matthew Thompson
VP Industrial Biotech


Luis Cascao-Pereira
Head of Digital Biology

Find Your Spot
Explore the full 2026 expo layout. Two halls, 100+ booths, specialty pavilions for AI, LATAM, and startups, plus a dedicated innovation stage.
Your Brand Doesn't Disappear After the Conference
SynBioBeta reaches the synthetic biology community 365 days a year. Sponsor our digital channels and stay in front of your audience between events.
Contact us to sponsor a newsletter.
The Topics Drawing Your Audience
SynBioBeta 2026 is organized around the fields driving the most investment, partnership activity, and commercial traction in biology right now.

AIxBIO
Foundation models & multimodal biological AI
Predictive design for drugs, materials & sustainable systems
Shared data + tooling for programmable biology
More

Planetary Health & Sustainability
Food & Agriculture
Climate Tech & Environment
Chemicals & Materials
Space Exploration
More

Human Health & Longevity
AI-powered drug discovery
Cell & gene therapies
Diagnostics & precision medicine
Engineered cells, tissues & therapeutics
More

Biomanufacturing at Scale
Continuous & precision fermentation
Modular, scalable bioprocesses
Real-time monitoring & control
Cost-competitive, low-carbon production
More

Tools, Tech & Platforms
Sequencing, synthesis, editing
Automation & cloud labs
BioCAD, ELNs & data platforms AI-driven discovery tools
More

Business of Biology
Commercializing biotech products
Scaling markets & go-to-market strategy
Funding, partnerships & investor insights
Regulatory, IP & bioeconomy strategy
More

